Delivery of Intensive Voice Therapy for Vocal Fold Nodules Via Telepractice: A Pilot Feasibility and Efficacy Study by Fu, Sherry et al.
  
Delivery of intensive voice therapy for vocal fold nodules via telepractice: A pilot 




Deborah G. Theodoros1 
Elizabeth C. Ward1,2 
 
1The University of Queensland, School of Health and Rehabilitation Sciences 
2Centre for Functioning and Health Research, Queensland Health 
 
 
Sherry Fu (Contact Author) 
Mailing address: 800 Chung San North Road, Section 6, Taipei, Taiwan. 
Tel: 886-953378136 





Summary: Objectives. This pilot study examined voice outcomes and patient 
perceptions following intensive voice therapy for vocal fold nodules via telepractice. 
Study Design. Pilot: within-subjects experimental trial 
Methods. Participants included 10 women diagnosed with bilateral vocal fold nodules 
who received intensive voice treatment via a free videoconferencing platform Skype, 
(Microsoft Corp., Redmond, WA).. All participants completed 1 vocal hygiene session 
in person, followed by 8 sessions of therapy via telepractice over 3 weeks. Before and 
immediately after treatment, patients attended a clinic in person to complete 
perceptual, stroboscopic, acoustic and physiological assessments of vocal function. 
Analyses were performed by a speech-language pathologist and an otolaryngologist 
independent to and blinded to the study. Participants also completed the Voice 
Handicap Index and a telepractice satisfaction questionnaire, or an anticipated 
satisfaction questionnaire, before and after treatment.  
Results. Significant improvements were found in perceptual, vocal fold function, 
acoustic and physiological parameters as well nodule sizes and patient perceptions of 
voice-related quality of life post treatment. Participants were highly positive about 
their first experience with telerepractice. Results were similar to those from a separate 
study investigating the effects of an intensive voice therapy delivered in conventional 
  
face-to-face format. 
Conclusions. This study is consistent with possible benefits of telepractice in the 
delivery of intensive treatment for vocal fold nodules. Pending final verification with 
a face-to-face comparison group, telepractice could be recommended as an alternate 
treatment modality for patients with vocal fold nodules. 
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INTRODUCTION 
The primary etiologic factor for vocal fold nodules is proposed to be cumulative 
perpendicular impact stress between the vocal folds over time, which increases with 
voice use.1 Certain forms of voice use, such as pressed voice, appear to increase the 
risk of injury.1 It has been well established that the presence of vocal fold nodules can 
lead to lost time at work, reduced productivity and impaired quality of life.2  
Many people with vocal fold nodules work in professions which have high vocal 
demands, therefore, it is essential that they recover their vocal function so that their 
ability to perform their jobs is not compromised.2 Several studies have been 
conducted on the efficacy of treatment for vocal fold nodules, with voice therapy 
recommended as first-line treatment.3-11 Although it has been established that voice 
therapy is often effective3-5,10,11, it has been noted that rates of therapy completion can 
be poor.12-15 This presents a challenge for clinicians and a critical barrier for full voice 
recovery in this patient population. 
As with other behavioural intervention, it is noted that effective delivery of oice 
therapy is impacted by problems of resistance to change, therapy dropout and lack of 
follow-through outside the therapy session.13-15 Numerous factors contribute to 
therapy non-compliance. However, ready access to services is a key factor. In many 
settings internationally, individuals work long hours with sometimes inflexible work 
  
conditions, or hold occupations that do not allow them to easily take time off work, 
which impact their ability to attend regular voice treatment sessions. For others who 
live in more regional or rural areas, the travel time associated with sometimes large 
distances needed to access clinicians experienced in voice disorders also can limit 
therapy attendance. Ultimately issues of access can contribute to missed appointments 
and a high dropout rate in the clinical population of individuals with vocal fold 
nodules. Such non-adherence to voice therapy not only affects treatment success, but 
also results in unnecessary extensions to treatment, and repeated examinations 
without sufficient behavioural change to effect improvement which lead to excess 
costs to healthcare and third-party payers. There is also a cost of cancellations and 
no-shows to healthcare.15 Furthermore, there may be loss of revenue or loss of 
employment as patients are unable to meet the vocal requirements of their 
occupations.12,15 Consequently, there is a need to explore ways to facilitate greater 
access to voice therapy to maximise attendance and ultimately enhance outcomes for 
people with vocal fold nodules and other conditions affecting voice.  
Recent research16 supports the efficacy of intensive voice therapy for vocal fold 
nodules. However, the ability to undertake such high intensity therapy programs (total 
program included 9 sessions over 3 weeks) in a traditional face-to-face (FTF) clinical 
model may not be possible for many patients due to the access issues previously 
  
discussed. Therefore, alternate modes of delivery for voice treatment need to be 
considered. One possible service delivery mode is telepractice, in which services are 
provided at a distance.17 A growing body of evidence is available to support the use of 
telepractice in speech pathology.18 Speech pathology services in general appear to be 
well-suited to telepractice delivery due to the audio-visual nature of the 
patient-clinician interaction in most consultations.  
A number of studies have explored the use of telepractice with various types of 
voice disorders. The majority of these have focussed on the assessment and treatment 
of voice disorders associated with Parkinsons Disease and revealed very positive 
outcomes.19-23 Only one investigation, however, has explored the use of telepractice 
with a group of patients with voice disorders of various aetiologies, including some 
patients with vocal fold nodules.24 Participants were treated via either conventional 
therapy or telepractice. All of the therapy sessions for the remote group were 
delivered in adjacent rooms via a real-time audio-video monitoring system. The 
system consisted of Sony Hi-8 video cameras with remote lapel microphone and 
colour monitors. In addition, FTF contact between patient and clinician was 
minimised as much as possible during the course of the conventional treatment 
protocol. The study found that both groups demonstrated improvements in voice 
quality, acoustic and physiological parameters post voice treatment. Furthermore, no 
  
significant differences were found between the extent of change in either group, 
indicating that voice therapy delivered via telepractice was as effective as 
conventional therapy.24 The authors suggested that the use of telepractice would be 
helpful in overcoming the barrier of geographic distance and eliminating the commute 
time to the clinic. In a later discussion article about this service published two years 
later, Mashima et al25 commented on their telepractice service model and its potential 
to increase accessibility and availability for patients with voice disorders.  
Although there is preliminary evidence supporting the use of telepractice in the 
management of various voice disorders, to date, no investigations have been 
conducted with a cohort of patients with vocal fold nodules, specifically, in 
telepractice. In addition, no studies have been performed with patients with vocal fold 
nodules receiving telepractice at home or in the workplace. Therefore, the aim of this 
pilot study was to investigate the feasibility and efficacy of telepractice in delivering 
intensive voice therapy to individuals with vocal fold nodules in their own homes or 
workplace. It is hypothesised that telepractice will be a service delivery mode which 





This study was approved by ethics committee at the Taipei Veterans General Hospital 
and a human research ethics committee at The University of Queensland.  
 
Participants 
Participants were recruited from the outpatient clinic at the Department of 
Otorhinolaryngology, Taipei Veterans General Hospital, Taiwan. For inclusion, 
participants had to present with bilateral vocal fold nodules, as determined by an 
otolaryngologist under stroboscopic examination, with planned behavioural 
management of the nodules by a speech-language pathologist (SLP). Participants 
were excluded from this study if they: 1) were not aged between 18 years and 55 
years; 2) had articulation, resonance, or language disorders; 3) had hearing 
impairment as determined by a screening test at 20 decibels hearing 
Level (dB HL) at 500, 1000, 2000 Hz; 4) had previous professional singing or 
speaking training; 5) had previous voice therapy or laryngeal surgical treatment; 6) 
used prescription medication which may cause changes in laryngeal function, mucosa 
or muscle activity (list provided by National Center for Voice and Speech [NCVS]26); 
7) had psychiatric or neurologic conditions; 8) had a history of allergies, lung disease, 
or other concomitant vocal pathology (e.g., vocal polyp and vocal cyst); 9) presented 
with bamboo nodules, or; 10) had no access to internet and SkypeTM.  
  
Ten women (mean age = 33.7 years, range =19 - 49 years) with vocal fold 
nodules and mild-moderate vocal impairments in perceptually evaluated voice quality 
were included in the study. Severity of dysphonia was determined from a recorded 
speech sample (a standard Mandarin passage) and rated using the “Grade” scale from 
the GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain) scale27 (where 0 = 
normal, 3 = severe). A single SLP experienced in the assessment and treatment of 
voice disorders but blind to the study purpose conducted the severity ratings. The 
participants’ occupations were categorised into non-professional voice users (eg., 
factory worker, student, catering, clerical worker, home carer, and unemployed) and 
professional voice users (eg., teacher, health professional, and sales personnel). The 
decisions on the extent to which various professions constituted professional voice 
use were made somewhat arbitrarily. All participants were diagnosed before treatment 
with bilateral broad-based nodules with surrounding oedema. The nodules were 
located at the midpoint of the membranous, vibrating vocal folds for all participants. 
None had had any previous experience with telepractice. Demographic information of 
the 10 participants is detailed in Table 1. 




Following recruitment, each individual attended the hospital clinic in person for a 
comprehensive baseline assessment of their voice and speech production. They then 
completed one vocal hygiene session in person, followed by eight sessions of 
intensive voice therapy delivered via telepractice from either their home or workplace 
(detailed in full below). Re-assessment at the clinic took place within 24 hours 
following completion of the final session of online therapy. 
 
Baseline and post treatment assessments 
Auditory perceptual ratings, stroboscopic assessments, acoustic and physiological 
measurements as well as patient perception questionnaires were completed before and 
after therapy. All auditory perceptual ratings, acoustic and physiological analysis was 
performed by one SLP experienced in voice disorders and blinded to this study, while 
all stroboscopic ratings were performed by one otolaryngologist independent and 
blinded to this study. 
 
Auditory perceptual ratings 
At each assessment interval, the participants were asked to read a five-sentence 
Mandarin passage. All voice samples were recorded with a Shure SM48-LC 
microphone (Shure, Niles, IL, USA) in a sound-treated room and stored in the 
  
Computerised Speech Laboratory system (CSL; model 4500, Kay Elemetrics Co.) at a 
4.41 KHz sampling rate. The desktop microphone was placed in front of each 
participant’s mouth at a distance of 15 cm. The microphone-to-mouth distance was 
established and maintained with a 15 cm ruler taped next to the microphone. The 
microphone was moved for each participant to be level with their mouth.  
All speech samples were subsequently analysed perceptually by one SLP with 15 
years experience assessing voice disorders. Voice quality was assessed using the 
GRBAS scale27 which consists of five perceptual parameters: grade (G), roughness 
(R), breathiness (B), asthenicity (A) and strain (S). Paired comparison ratings of 
GRBAS parameters were conducted using the Comparison Mean Opinion Score 
(CMOS) process.28 The order of the voice samples were randomised with respect to 
time points (pre versus post treatment) within each participant’s paired samples to 
reduce potential expectation bias prior to the rater listening to and comparing the 
paired speech samples. A clinician independent of the rating process created 10 pairs 
of recorded speech samples for each participant relating to the assessment time points 
and the five GRBAS perceptual parameters (ie, pre and post voice therapy, with a 
total of 20 samples or a total of 100 voice ratings). After listening to each pair of 
speech samples, the rater then rated sample 2 in relation to sample 1 on a scale of -3 
to +3, in which 0 indicates the samples are equal. If the value is positive, it indicates 
  
that sample 2 is better than sample 1 (+1 mildly better; +2 better and +3 much better). 
However, if the value is negative, it indicates that sample 2 is worse than sample 1 (-1 
mildly worse; -2 worse and -3 severely worse). The SLP was able to listen and 
compare the speech samples as often as needed. Once the paired samples were rated, 
the principle investigator revealed the order of the two samples and transposed the 
scores to ensure data accurately reflected perceptual differences relative to the time of 
speech sample recording such that any positive score indicated an improvement and 
negative values indicated a decline in function.  
To validate the reliability of the primary rater, a second SLP with nine years 
experience assessing voice disorders listened to and rated a random set of 20 voice 
ratings (20% of the total voice ratings). Inter-rater reliability was calculated using 
direct calculation of the Percent Exact Agreement (PEA) and the Percentage of Close 
Agreement (PCA - where raters differed by no more than 1 scale point). Findings 
revealed an overall PEA was 80% and the PCA was 100%. Intra-rater reliability was 
calculated by having the primary rater re-rate 20% of the sample a second time, at no 
sooner than four weeks following initial assessment. The mean PEA was 80% and 
PCA was 100%.  
 
Stroboscopic evaluation –vocal fold function and lesion ratings 
  
The stroboscopic recordings were performed during the sustained phonation of the 
vowel /i/ produced at a comfortable loudness and pitch. The examination procedure 
was conducted by any one of four otolaryngologists at any assessment point. The 
recorded stroboscopic samples were then subsequently rated by one primary 
otolaryngologist with 10-year experience in assessing voice disorders, blinded to the 
assessment points.  
The stroboscopic ratings were performed in two stages. The first stage was to 
complete ratings of vocal fold function and lesion including: the symmetry of vocal 
fold abduction and vibration; the regularity and amplitude of the vocal fold movement; 
vocal fold edge smoothness; mucosal wave characteristics and glottal closure (0 = 
normal; 1 = mild; 2 = moderate; 3 = severe); nodule location (very front, front, mid, 
back of the vocal fold membranous portion); nodule shape (narrow-based, 
broad-based) and surrounding oedema (yes/no). The 20 samples (10 participants by 
two samples per participant) were randomized prior to presentation to the 
otolaryngologist for rating in order to reduce any potential bias. The otolaryngologist 
was able to review each stroboscopic sample for as long as required to complete the 
ratings. The stroboscopic samples were viewed and rated without sound.   
The second stage of the stroboscopic rating process used the paired sample 
comparison process (as described previously) to rate paired samples (pre and post 
  
voice therapy) using a questionnaire adapted from Holmberg, Hillman, Hammarberg, 
Sodersten, and Doyle.5 Ratings of sample two compared to sample one were rated for 
changes in: (1) nodule size (difference between the two recordings, -1 larger; 1 
smaller; 0 no difference), and; (2) surrounding oedema (difference between the two 
recordings: -1 larger; 1 smaller; 0 no difference). Once the samples were rated, the 
order of the samples was revealed to the principle investigator who then transposed 
the scores to ensure data accurately reflected differences relative to the time of 
videostroboscopic sample recording (pre-voce therapy and post-voice therapy). 
The reliability of the primary rater was determined using a second 
otolaryngologist with ten years experience assessing voice disorders who rated a 
random set of four samples (20% of the total stroboscopic samples). Inter-rater 
reliability of the ratings in first and second stage was calculated using PEA and PCA. 
Findings revealed PEA was 65% and PCA was 97.5% respectively for stroboscopic 
parameters. Intra-rater reliability of the ratings in first and second stage was 
calculated by having the primary rater re-rate 20% of the sample a second time, at no 
sooner than four weeks following initial assessment. The PEA calculated for 




Measures of maximum phonation time (MPT), mean airflow rate (MFR) and 
subglottic pressure were included in the aerodynamic assessment. MPT was measured 
with a stopwatch while participants were asked to produce the sustained vowel /a/ for 
as long as possible at a comfortable loudness and pitch level on a single breath, three 
times. The MFR and subglottic pressure were obtained and analysed using the 
Aerophone II (Model 6800, Kay Elemetrics Co., Lincoln Park, NJ). For MFR 
measurement, each participant was asked to produce a sustained vowel /a/ for as long 
as possible at a comfortable intensity and pitch level with a face mask, sealed over the 
nose and mouth connected to a pneumotachograph- based flow system, three times. 
The middle portions of each sustained vowels were used for analysis. Subglottal 
pressure was estimated indirectly using an intraoral pressure probe positioned behind 
the lips and resting on the tongue. The participants were asked to repeat at least five 
/ipi/ at a comfortable pitch and loudness, however with constant loudness once 
initiated, with the face mask and probe in place at a rate of 1.5 syllables/second, three 
times. Results for each parameter were averaged to generate one single value which 




The participants were asked to produce a sustained vowel /a/ on one breath at a 
comfortable pitch and loudness level, three times. Vowel productions were recorded 
via the desktop microphone of the Computerized Speech Lab (CSL) (Model 5105; 
Kay Elemetrics, Co., Lincoln Park, NJ, USA). The microphone was positioned in 
front of the participant with a mouth-to-microphone distance of 15 cm. The 
microphone-to-mouth distance was established and maintained with a 15 cm ruler 
taped next to the microphone. The microphone was moved for each participant to be 
level with their mouth. Each participant’s production of sustained /a/ was analysed 
using the Multi-Dimensional Voice Program (MDVP) software in the CSL. All 
acoustic recordings were conducted in a sound-proof room. The middle 3-second 
segment from each of the sustained vowels was selected for acoustic analysis. 
Detailed acoustic measures included: vocal fundamental frequency (F0) (Hz), mean 
percentage vocal jitter and shimmer, and noise-to-harmonics ratio (NHR) (dB). 
Results across the three vowel phonations were averaged to produce a single value for 
each measure. Furthermore, participants’ vocal intensity (dB) for the three prolonged 
vowels /a/ and additional conversational speech samples were simultaneously 
measured using Sound Level Meter (320 series, Center Technology Corp., Taiwan) 
which was also positioned in front of the participant with a mouth-to-microphone 
distance of 15 cm. Vocal intensity recorded for the prolonged vowel phonations and 
  
conversational speech samples were also averaged to produce a single value for each 
measure. 
 
Voice handicap index 
The Chinese version of the Voice Handicap Index (VHI)29 was used to quantify 
self-assessment of voice-related quality of life. The VHI is a 30-item instrument 
consisting of three domains: emotional (VHI-E), physical (VHI-P), and functional 
(VHI-F) aspects (each 10 questions). A total score (ranging from 0 to 120) and each 
individual VHI subscale scores (ranging from 0 to 40) were generated. A lower total 
score represents less perceived voice-related quality of life problems.  
 
Participant satisfaction questionnaires 
To evaluate the patients’ perceptions of the telepractice sessions, a 16-item 
questionnaire modified from Sharma et al30 was administered both immediately prior 
to and after voice therapy. In the pre-session questionnaire, the questions were worded 
in the future tense while the post-session questionnaire contained the same questions, 
only with grammatical modifications to reflect past tense (i.e. I will have/had no 
difficulty in seeing online speech pathologist). All participants responded to all 
  
questions using 5-point Likert scale (1 = strongly disagree, 3 = neutral/unsure, 5 = 
strongly agree).  
 
The telepractice system 
The telepractice system used to conduct the therapy sessions consisted of two 
computers (one at clinician end and one at participant end) that were equipped with 
videoconferencing software (SkypeTM; a peer-to-peer Internet telephony network), a 
web camera and microphone (Fig. 1). Although it is acknowledged that SkypeTM may 
have security issues, it was nevertheless used as this technology was the only readily 
available platform for use in Taiwan for this population. All participants were fully 
informed of this limitation and gave consent to the use of SkypeTM for the voice 
treatment. Videoconferencing was established over a broadband internet connection 
with at least 2M/64K (download/upload) speed between the clinic and the 
participant’s home or workplace. Participants were required to have an account with 
SkypeTM, and e-mail contact with the clinician. All aspects of treatment were 
delivered remotely by the principal investigator. To ensure there was satisfactory 
visual and auditory information exchanged between the participants and clinician, 
specific equipment was used. Visual information was optimised through the use of 
web cameras (5 million pixels; Ktnet Enterprise, Co., Ltd., Taichung, Taiwan). The 
  
web camera was clipped on the computer screen and the camera head could be moved 
and adjusted according to the participant and SLP’s position and height. There were 
six LED lights on the web camera which could be switched on if a better light source 
was required. To enhance the auditory signal, and reduce background noise, a 
freestanding/desktop microphone (Jazz-005; Intopic International, Co., Ltd., Taipei, 
Taiwan) was used at both the clinician and participant sites. The microphone was 
fixed on an adjustable mobile platform that allowed the participant and clinician to 
move and adjust the microphone position and height accordingly. 
 
Therapy program 
All participants completed 9 sessions of intensive therapy delivered across three 
therapy sessions per week over a 3 week period. This intensive therapy model was 
previously reported by Fu et al (in press) and found to provide comparable outcomes 
to a traditional non-intensive therapy model. In week 1, for the first session 
participants attended in person for a session on vocal hygiene (adapted from 
Weinrich31, Verdolini Abbott32, and NCVS33) and also to receive information 
regarding the technology requirements and set-up for the subsequent eight online 
voice therapy sessions. The remaining 2 sessions in week one, and then all 3 sessions 
in weeks 2 and 3 were conducted via telepractice (8 telepractice sessions). In addition 
  
to the therapy sessions, all participants were required to complete homework activities 
using written resources provided via email. Participants were instructed to complete 
this homework practice in two 15-minutes sessions per day on a non-treatment day 
and in a one 15-minute session on a treatment day.  
The online voice therapy was provided by the principle investigator who was not 
involved in assessment of the participants. The principle investigator was trained and 
certified to provide the therapy program which was adapted from the Lessac-Madsen 
Resonant Voice Therapy (LMRVT) program developed by Verdolini Abbott32,34. 
Components of the Vocal Function Exercises (VFE) program developed by Stemple35 
were also incorporated in the speech tasks. Full details of the therapy program are 
published elsewhere.16 In summary, it contained relaxation exercises32 followed by 
basic training gestures as described by Verdolini Abbott34 and Roy et al.36 The 
sessions of direct facilitation of speech tasks proceeded in stages to a conversational 
level and real-life applications outside the therapy room. All resource materials used 
during therapy (ie., words, phrases, sentences and reading passages for speech tasks) 
were provided via email prior to each session. 
 
Statistical analysis 
The Statistical Package for the Social Sciences (SPSS) version 20 (SPSS, Inc., 
  
Chicago, IL) was used for all statistical analysis and level of significance was set at 
p<0.05. Although multiple statistical analyses were conducted, due to the preliminary 
nature of the study, more stringent alpha levels to protect inflation was not adopted. 
Paired comparison ratings (between pre to post treatment) conducted for the 
perceptual parameters of grade, roughness, breathiness, asthenia, strain and also for 
the static parameters of nodule size and oedema were analysed using a series of one 
sample t-tests (one-tailed) where 0 was taken to indicate no difference between the 
sample pairs. For the vocal fold functions ratings of the symmetry of vocal fold 
abduction and vibration; the regularity and amplitude of the vocal fold movement; 
vocal fold edge smoothness; mucosal wave; and glottal closure, analysis were 
conducted using Wilcoxon signed rank tests to explore extent of change across the 
two time points (baseline and post voice treatment). To determine whether significant 
changes occurred in acoustic and physiological parameters after therapy, paired 
sample t-tests were performed. 
Analysis of VHI data pre post treatment was conducted using Wilcoxon-Signed 
Ranks test. Participants’ responses to the telepractice questionnaire were collapsed 
from a 5-point scale to three groups (i.e., strongly disagree + disagree = “disagree”, 
unsure = “unsure”, and agree + strongly agree = “agree”). The Friedman test was then 





All participants completed the full telepractice voice program, with 100% attendance. 
One of the sessions had to be re-scheduled due to technical difficulties with webcam 
connection. This could not be solved during the session and the elderly participant 
required assistance from a family member. The problem was solved within 24 hours 
and the session continued as normal. The participant completed the rest of the 
treatment with good attendance. Five out of the eighty sessions (6.25%) had delays 
between audio and visual images during sessions but these delays did not affect the 
integrity of the treatment. Three out of the eighty sessions (3.75%) experienced loss 
of connection but reconnected straight away. In addition, participants demonstrated 
high compliance with homework activities, reporting that they practiced at least once 
a day as recommended during the course of treatment. 
 
Auditory perceptual ratings 
Comparison between baseline and post treatment perceptual ratings demonstrated 
significantly (p < 0.05) improved ratings of overall voice quality, roughness, and 
weakness of voice (Table 2). Individual analysis revealed all participants were rated 
  
as having better voice post treatment in overall voice quality and roughness, six had 
reduced weakness and three had reduced strain post treatment. Breathiness did not 
change in any participant. 
    [Table 2 near here] 
 
Stroboscopic ratings – vocal fold function and lesion ratings 
Vocal fold function assessment revealed statistically significant (p < 0.05) 
improvements across the group from baseline to post treatment for ratings of mucosal 
wave, vocal edge smoothness and glottal closure (Table 3). No significant change was 
found for symmetry of vocal fold abduction, amplitude of vocal fold movement and 
regularity of vocal fold movement. 
    [Table 3 near here] 
The paired comparison ratings for nodule size and oedema (baseline and post 
treatment) were analysed using a series of one sample t-tests. Post-treatment results 
revealed all ten of the participants were rated as having smaller nodule size when 
compared to pre-treatment. Ratings of vocal fold oedema was shown to have 




Physiological and acoustic assessments 
A series of paired sample t-tests were conducted to examine the impact of intervention 
on each physiological parameter. Results revealed significant increase in MFR, while 
no changes were found in MPT and subglottal pressure following treatment (Table 4). 
Individual analysis demonstrated that post treatment eight participants had an increase 
in MFR, five had an increase in MPT and seven increased their subglottic pressure.  
Paired-samples t-tests revealed a significant increase in mean F0, and significant 
reductions were shown in jitter, shimmer and NHR following treatment (Table 5). 
Results of vocal intensity of prolonged vowel /a/ and conversation demonstrated no 
significant differences between baseline and post treatment. Individual analysis 
showed post treatment all participants had an increase in F0, all had reduced jitter, and 
nine had reduced shimmer and NHR. With regards to vocal intensity post treatment, 
eight had an increase during the prolonged vowel /a/ and five demonstrated an 
increase in vocal intensity during conversation.  
    [Tables 4 & 5 near here] 
 
Voice handicap index 
Significant improvement in patient perceptions of voice function was observed 
following treatment (Table 6). Almost all of the participants had lower total scores 
  
after treatment (Figure 2). With regard to the individual VHI subscales, results for the 
VHI-P showed significant improvement post treatment, while VHI-F and VHI-E 
showed no significant differences before and after treatment (Table 6). 
   [Insert Table 6 and Figure 2 near here] 
 
Participant satisfaction questionnaires 
Pre-treatment some of participants were uncertain about their anticipated level of 
comfort with telepractice, the visual and audio quality, comprehensiveness of 
instructions, sufficient time to execute instructions given, opportunity to clarify 
doubts, replacement of FTF consultation with telepractice consultation, accessibility 
to healthcare with telepractice, and preference of telepractice over FTF consultation 
(Table 7). However, post treatment these aspects had significantly improved. No 
significant changes were observed on Questions 3, 12, 13, 15 and 16, with 
post-treatment opinions similar to pre-treatment. Even before treatment they agreed 
with these statements.  
    [Insert Table 7 near here] 
 
DISCUSSION 
The aim of the present study was to examine the feasibility and efficacy of delivering 
  
intensive voice therapy via telepractice. Overall the results revealed positive treatment 
effects which are quantitatively comparable to previous research16,37,38 on 
conventional FTF voice therapy for vocal fold nodules, and a high level of patient 
satisfaction. Sessions were well attended and delivered with minimal technical 
difficulty. Consequently, this investigation provides a preliminary indication that 
telepractice is a viable service delivery mode for providing intensive voice therapy for 
people with vocal fold nodules.  
In the current investigation, it was found that after therapy there were 
significantly improved ratings on perceptual parameters of voice quality, specifically 
overall voice quality, roughness, and weakness of voice. These changes were parallel 
to positive changes in vocal fold function, with stroboscopic ratings showing 
improvements in mucosal wave, vocal fold smoothness, and glottal closure. In 
addition, positive changes in acoustic parameters were also observed. These findings 
are consistent with the patterns of the positive change observed following intensive 
therapy delivered in the traditional FTF manner. 16 They were also similar to the 
positive outcomes in perceptual, vocal fold and acoustic function observed by 
Mashima et al24 in their larger group of patients with voice disordered treated by 
telepractice. Unlike prior research by Fu et al16 additional positive changes were also 
observed in physiological (aerodynamic) functions across the group. There was a 
  
significant increase in MFR post online voice therapy, which may reflect improved 
regulation of the mean resistance of the glottal airway and possibly, an overall 
improvement in vocal fold function in this cohort. This premise was supported by the 
fact that vocal fold function tended to improve across all stroboscopic parameters 
post-treatment (See Table 3), although mucosal wave, vocal fold edge smoothness, 
and glottal closure were the only parameters found to be significantly altered. A 
possible explanation for the difference in outcome between the current study and that 
of Fu et al 16 may be due to the individual variability in such a small cohort of 
participants, therefore, further research on a larger number of study group may be 
needed for clarification. Overall, the current findings provide further evidence to 
support the positive effects of delivering voice treatment via telepractice. 
Apart from the positive outcomes shown in perceptual, vocal fold function, 
acoustic and physiological measures, participants’ perception of changes in vocal 
function post treatment is an important indicator of the efficacy of treatment. It is 
recognised that how a patient feels about his/her voice-related quality of life is one of 
the determining factors in treatment seeking, compliance, and discharge.39 The results 
of this study showed that the total VHI score decreased significantly, indicating that 
the participants had better perception of their voice-related quality of life after 
treatment. These results are similar to previous research37,38 which has reported 
  
improvements in total VHI score following voice therapy delivered in the traditional 
FTF modality. Overall the current results support that patients perceived a positive 
benefit from the therapy they received via telepractice. 
Exploring participant perception is an important component in the evaluation of 
any novel service delivery model. The satisfaction questionnaire conducted to explore 
participant perceptions of the telepractice service confirmed that participants were 
highly positive about their first experience with telepractice. Pre-treatment it was 
noted that patient expressed some concerns about using telepractice particularly 
regarding audio/visual issues, however these were resolved post-treatment. Similar 
data were reported by Sharma et al30 from their patient cohort who were to undergo 
dysphagia assessment remotely. As discussed by those authors,30 identification of any 
patient concerns pre-treatment can enable clinicians to address these concerns prior to 
sessions commencing. Pre and post treatment, the majority saw telepractice as a way 
to improve access to healthcare, save time and money and believed telepractice to be 
a viable option to FTF therapy. These findings are consistent with much of the 
literature, 19,30,40,41 with patients’ perception of telepractice services in general to be 
very positive. The results also align with the comments made by Mashima et al25 
about the benefits of delivering voice therapy via telepractice. 
Although the results of the current trial were generally positive, some technical 
  
difficulties impacted the quality of some sessions. In a few sessions occasional delays 
between audio and visual images during the therapy sessions were noted. Furthermore, 
in a few sessions the SkypeTM connection was lost and reconnected. There was only 
one session where there was complete inability to reconnect and the session was 
cancelled. Contributing to technical difficulties experienced in this study were the 
sometimes low and varying bandwidth connections into the individual’s 
homes/workplace. However, these issues did not appear to have a negative impact on 
treatment outcomes in the current study. This finding is consistent with previous 
telepractice research24,42 using low bandwidth connections where outcomes were not 
substantially affected by audio and visual quality loss. Further research is necessary 
however in order to establish appropriate technical standards and guidelines for the 
use of telepractice in the management of voice disorders.  
Despite evidence of therapeutic benefits, there are limitations in this study. One 
limitation was the use of SkypeTM, the free consumer-based voice and video over the 
Internet Protocol (VoIP) software system. Whilst the participants were fully informed 
and gave consent to use this software and felt comfortable using the program for 
therapy, several studies43-45 have expressed concerns for privacy and security of the 
therapy sessions. Future investigations, using more secure, low cost systems would 
enable public health privacy and security regulations to be optimised. Another 
  
limitation of the study was that only a small cohort was included in this pilot study. 
Future studies should be conducted on a larger number of participants to ensure the 
magnitude of outcome effect is not over-estimated. Including a parallel group treated 
via FTF would also enhance the strength of the research design by enabling validation 
of the online treatment mode. It would also be of benefit to conduct long-term 
follow-up on the investigated measures to examine whether the treatment effects were 
maintained. Finally, it is acknowledged that the vocal hygiene session may have been 
a contributing factor to the positive outcomes observed in the cohort. In a larger 
study16 of conventionally delivered voice therapy no significant differences in 
perceptual, acoustic or physiological (aerodynamic) parameters were observed from 
pre to post vocal hygiene session. However, the therapeutic benefit of the FTF vocal 
hygiene session cannot be completely discounted.   
 
CONCLUSION 
This pilot study provided evidence that supports telepractice as feasible and 
potentially effective in delivering intensive voice therapy to individuals with vocal 
fold nodules. In this investigation, significant improvements were found in perceptual, 
vocal fold function, acoustic and physiological parameters post therapy. There were 
positive changes in participants’ perception of their voice and the effects of their voice 
  
on their life after voice treatment. Overall, the participants were satisfied with the 
intensive voice therapy provided through telepractice delivery. These results may 
possibly indicate the effectiveness of treatment was not reduced by the distance mode. 
This service delivery mode could be recommended as one of the treatment options for 
patients who are unable to attend conventional FTF voice therapy and have urgent 
need to recover their voice within a short period of time. There is also a need for 
future studies involving the management of voice disorders via telepractice which 
utilize secure standards-based technologies.  
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Table 1. Demographic Information of Participants 
Demographic variables  
Total number of participants 10 
Mean age 33.7 
Severity of dysphonia    
   Mild-moderate 8 
   Moderate 2 
Occupations  
   Professional voice user 6 
   Non-professional voice  
   User 
4 
  
Table 2. Results of the One Sample t-tests and the Proportion of Change in Perceptual Ratings 
Parameter Rating n (%) Mean difference t Test P Value 
Grade Post-treatment better 10 (100) 1.2 9.00 <0.001* 
 No change 0 (0)    
Roughness Post-treatment better 10 (100) 1.2 9.00 <0.001* 
 No change 0 (0)    
Breathiness Post-treatment better 0 (0) N/A N/A N/A 
 No change 10 (100)    
Asthenia Post-treatment better 6 (60) 0.6 3.674 0.005* 
 No change 4 (40)    
Strain Post-treatment better 3 (30) 0.3 1.964 0.081 
 No change 7 (70)    
Abbreviation: N/A, not available. 
* Significant at P < 0.05.
  
Table 3. Results of Analysis of Strobosopic Ratings 
Parameter Pre-treatment, Mean (SD) Post-treatment,  Mean 
(SD) 
Z P Value 
Symmetry 1.3 (0.675) 1.0 (0.471) -1.732 0.83 
Amplitude 1.4 (0.699) 1.0 (0.667) -1.265 0.206 
Mucosal wave 1.8 (0.919) 1.1 (0.738) -2.111 0.035* 
VF edge smoothness 1.5 (0.527) 1.1 (0.316) -2.000 0.046* 
Regularity 1.4 (0.516) 1.2 (0.632) -0.707 0.480 
Glottal closure 1.4 (0.516) 0.8 (0.422) -2.449 0.014* 
Abbreviation: VF = vocal fold. 






Table 4. Results of Analysis of Physiological Parameters 
Parameter Pre-treatment, Mean (SD) Post-treatment, Mean (SD) t Test P Value 
MPT 6.21 (1.76) 6.63 (2.55) -0.681 0.513 
MFR 131.97 (77.16) 167.00 (80.38) -2.469 0.036* 
Subglottic pressure 9.30 (1.93) 9.81 (1.18) -0.993 0.347 
Abbreviation: MPT, maximum phonation time; MFR, mean airflow rate; SD, standard deviation.  
* Significant at P < 0.05. 
 
  
Table 5. Results of Analysis of Acoustic Parameters 
Parameter Pre-treatment, Mean (SD) Post-treatment, Mean (SD) t Test P Value 
F0 186.03 (30.48) 232.01 (44.16) -7.437 <0.001* 
Jitter 1.81 (0.91) 1.09 (0.75) 3.181 0.011* 
Shimmer 4.95 (1.30) 3.74 (1.04) 3.700 0.005* 
NHR 0.17 (0.03) 0.13 (0.14) 3.246 0.010* 
VI of prolonged /a/ 72.73 (5.56) 77.74 (8.72) -1.973 0.080 
VI of conversation 69.84 (3.28) 69.96 (4.95) -0.110 0.915 
Abbreviation: F0, fundamental frequency; NHR, noise-to-harmonic ratio; VI, vocal intensity; SD, standard deviation.  
* Significant at P < 0.05.
  
Table 6. Summary of VHI Scores Before and After Treatment 
Subscale item Pre-treatment, Mean (SD) Post-treatment, Mean (SD) Z P Value 
VHI-F 15.3 (7.379) 12.8 (6.763) -1.011 0.312 
VHI-P 25.3 (8.233) 17.6 (6.883) -2.807 0.005* 
VHI-E 13.4 (9.559) 11.4 (0.879) -0.869 0.385 
VHI total score 54 (21.965) 41.8 (22.075) -2.199 0.028* 
Abbreviation: VHI, Voice Handicap Index; VHI-F, functional domain; VHI-P, physical domain; VHI-E, emotional domain; SD, standard 
deviation.  




Table 7. Results of Participants Perception of Telepractice Service Pre- and Post- Voice Therapy which have been Concatenated from a 
5-point Likert Scale to a 3-point Likert Scale to Reveal Basic Groups of “disagree”, “unsure”, and “agree”.  













Z P Value 
1. I will be comfortable (am 
comfortable) to use telepractice if it 
is available in the hospital or 
healthcare facility nearest to my 
place of residence. 













2. I am (was) comfortable to undergo 
voice therapy via telepractice. 







3. I would rate the online treatment as 
being equal to a treatment provided 

















4. The instructions given during the 
online voice therapy will be (were) 
clear and easy to follow.  










5. I will have (had) no difficulty in 
seeing the online speech 
pathologist. 










6. I will have (had) no difficulty 
hearing the online speech 
pathologist. 










7. I will have (had) sufficient time to 
execute the instructions given 









during the treatment.    
8. I will have (had) opportunities to 
clarify any doubts I may have 
during the online treatment. 










9. I will be (was) comfortable being 
online and would consider using the 
internet for the rehabilitation of my 
voice problems. 













10. Telepractice can replace a 
face-to-face voice therapy. 







11. Telepractice will allow easy access 
to healthcare. 
0 (0) 1 (10) 9 (90) 0 (0) 0 (0) 
10 (100) 
 -2.00 0.046* 




time & money.    
13. Telepractice may benefit all patients 
alike. 







14. I would prefer to have a telepractice 
consultation with the speech 
pathologist over a face-to-face 
consultation. 













15. I would prefer to have a face-to face 
consultation with the speech 
pathologist over a telepractice 
consultation. 













16. I would prefer to have a 
combination of face-to-face and 

















Notes: The italics and brackets indicate pre-/post- wording changes between the pre- and post-therapy conditions. 















Figure 2. Individual results of Voice Handicap Index scores preand 
post-treatment. 
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